Eric Ducournau

What does the Chamber of Pharmacists do ? It ensures the respect of professional duties in the interest of public health. In this context, the Chamber undertakes several actions: - Conciliation and assistance to colleagues. Ordinal conciliator advisors help their colleagues reach an amicable solution, when possible. - Disciplinary chamber: Any complaint is referred to a disciplinary chamber in case of failed conciliation, partial conciliation, or when the complaint comes from a public authority.

8

Life is Good

11

Leveraging RADAR, CRA’s orphan drug data repository, our #CRALifeSciences practices delves into pricing and market access trends of rare disease treatments in France. Several innovative pharmaceutical products have navigated the complex landscape of reimbursement over extended periods, exceeding five years for some due to prolonged time to clinical trial outcomes. Orphacol stands out as a remarkable achievement, being the sole product to achieve ASMR 1 status since 2013, granted within an impressive 160 days of EMA approval on its first submission. Additionally, Strensiq, Luxturna, Givlaari, and Kaftrio have attained ASMR 2, with early access through ATU preceding reimbursement, except for Strensiq. Furthermore, 32 products, averaging three per year, have secured ASMR 3, with five falling into mixed ASMR categories, including nine with reimbursement restrictions, reflecting the dynamic landscape of pharmaceutical reimbursement and access. For more information, click here: https://lnkd.in/gVEh-zps

42

4Moving Biotech (4MB), a clinical-stage subsidiary of 4P-Pharma specializing in immuno-inflammation and #osteoarthritis, is pleased to announce the appointment of Luc Boblet as Chief Executive Officer. The company, having successfully completed its Phase I clinical trial and a preparatory in silico Phase 2 analysis, looks to Luc Boblet's seasoned expertise in biotech entrepreneurship and strategic #development to guide the forthcoming stages of clinical proof of concept and early market access. Luc Boblet, a biotech entrepreneur with two decades of experience, joins 4MB following his tenure at Egle Therapeutics, where his leadership was essential in advancing novel immunotherapies and securing a robust Series A funding backed by a big pharma strategic alliance. His previous roles included founding and leading companies such as H-IMMUNE - acquired by HiFiBIO - and Pathoquest, where he excelled in driving innovation, closing fundraising and forging strategic #partnerships as instrumental catalyst of growth.  Revital Rattenbach, founder and CEO of 4P-Pharma and co-founder of 4Moving said, "Luc's appointment comes at a turning point for 4Moving Biotech as we have concluded a milestone Phase I trial for our leading drug candidate and are advancing strategic discussions with the FDA, toward potential accelerated approval" "His track record in steering biotech ventures and his strategic approach to partnerships will be invaluable as we advance our clinical programs and explore opportunities for pharma co-development and partnership." Luc Boblet, CEO of 4Moving Biotech said: "The opportunity to lead 4Moving Biotech at this juncture is one that is aligned with my commitment to bringing pioneering therapies for untreated severe diseases. The company's progress in drug development and the potential to significantly improve patient outcomes in osteoarthritis is a strong foundation for future success. I am looking forward to applying my experience in corporate strategy business development to deliver our value proposal and establish meaningful partnerships." francis berenbaum To share your startup story write us on - [email protected] #4PPharma #osteoarthritis #Biotech #immunotherapies #news #appointment #startup

89

6 commentaires

🚀 Exciting News! 🚀 I had the incredible opportunity to be featured on BFM TV to discuss the innovative work we are doing in the field of digital pathology. 🎥🧬 In this 2-minute interview, I delve into how our cutting-edge technology is revolutionizing pathology by enhancing diagnostic accuracy and speeding up results for patients and healthcare providers alike. Check out the video below to learn more about our mission and how we are shaping the future of pathology.

84

4 commentaires

C est incomprehensible

3

📸 Save the date 📸

16

What does the Chamber of Pharmacists do ? Ensuring the Respect of Professional Duties. Our commitment to professional integrity is unwavering. By acting against threats to our profession, we protect the reputation and value of pharmacy. The code of ethics, which guides our practice, is developed by the Chamber. Our role is to ensure its compliance. Together, we shape a solid and ethical professional future for pharmacy and society.

10

🔥🔥TOP 8 DES ALIMENTS ANTI INFLAMMATOIRES... 🔥🔥 #tondernierregimeaveclabnc #moins8kgen40jours #labncfonctionne #bionutritioncellulaire #bnc #regimebnc #regime #regimeyoyo #microbiote #probiotiques #microbioteintestinal #pertedepoids #pertedepoidsdurable #grignotage #mincirduventre #ventreplat #mincirsanssport #mincirsansprivation #sucre #detox #detoxsucre #kilosenmoins #obesite #sleeve #thyroide #kilodegrossesse #maman #challengeminceur #france #canada #europe

3

CREATION IT IS A PROCESSUS

49

2 commentaires

AMR is a global challenge. It is already a critical risk in Intertropical Africa for the animal production which is growing much faster than the field training on the rational use of antiinfectives especially in poultry production. Solutions already exist and should be deployed to built a consistent chain of competencies including field vets, technicians and farmers. It is feasible https://lnkd.in/dsxQ5mPW #ceva #GALVmed

2

🚀 Exciting News from Advanced BioDesign! 🚀 We are thrilled to announce that Advanced BioDesign is accelerating the #ODYSSEY clinical study with a new design, following the highly promising initial results of ABD-3001 in AML (Acute Myeloid Leukemia). Stay tuned for more updates as we continue to push the boundaries of cancer treatment and research. #AdvancedBioDesign #ClinicalResearch #AML #CancerResearch #Innovation

87

2 commentaires

WEBINAR | Listen to our expert speakers Yves Buelens, Jean-Christophe Moreau and Christophe Schwoehrer explain blow-fill-seal (BFS) technology and the unique benefits of unidose BFS for ophthalmics, biologics and other sterile drug products. Webinar learning objectives: 1. What is BFS technology and the unique benefits of unidose BFS 2. What are the advantages of BFS unidose format in comparison to ocular multidose or glass vial format? 3. How can a CDMO support pharma companies in switching to unidose BFS Watch on demand here : https://lnkd.in/d9TRp6ZV

32

La base de la naturopathie

3